Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers

Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers

US Patent 10064835 · Granted Sep 4, 2018

Estimated economic value: $72,315,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and system for managing patient healthcare2015
Compositions including beta-hydroxy-beta-methylbutyrate2014
Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated2014
Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditio2014
Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating di2014
Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate2013
HMB uses thereof2012